STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms

🇺🇸 STAT News Health (US) —
STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms

AI Summary

The outcome of the U.S. midterm elections could bring major changes to drug pricing, Medicaid, and medical research funding. Those policy shifts would affect hospitals and pharmaceutical companies.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

Politics Markets Health U.S. midterms drug pricing Medicaid research funding health policy pharmaceuticals

Read original source →